DK175809B1 - Fibronectinbindende protein - Google Patents

Fibronectinbindende protein Download PDF

Info

Publication number: DK175809B1
Authority: DK; Denmark
Prior art keywords: gaa; gag; caa; gat; ggt
Prior art date: 1988-05-20

Application number

DK198902442A

Other languages

Danish (da)

English (en)

Other versions

DK244289D0 (da

DK244289A (da

Inventor

Magnus Hoeoek

Martin Kjell Lindberg

Lars Christer Signaes

Per-Eric Lindgren

Original Assignee

Alfa Laval Agri Internat Aktie

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-05-20

Filing date

1989-05-19

Publication date

2005-03-07

1989-05-19 Application filed by Alfa Laval Agri Internat Aktie filed Critical Alfa Laval Agri Internat Aktie

1989-05-19 Publication of DK244289D0 publication Critical patent/DK244289D0/da

1989-11-21 Publication of DK244289A publication Critical patent/DK244289A/da

2005-03-07 Application granted granted Critical

2005-03-07 Publication of DK175809B1 publication Critical patent/DK175809B1/da

Links

102000036072 fibronectin binding proteins Human genes 0.000 title claims description 28
101000815632 Streptococcus suis (strain 05ZYH33) Rqc2 homolog RqcH Proteins 0.000 title claims description 18
108090000623 proteins and genes Proteins 0.000 claims abstract description 45
102000016359 Fibronectins Human genes 0.000 claims abstract description 39
108010067306 Fibronectins Proteins 0.000 claims abstract description 39
230000027455 binding Effects 0.000 claims abstract description 33
102000004169 proteins and genes Human genes 0.000 claims abstract description 33
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 16
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 14
108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 12
241000194042 Streptococcus dysgalactiae Species 0.000 claims abstract description 12
229920001184 polypeptide Polymers 0.000 claims abstract description 12
241000588724 Escherichia coli Species 0.000 claims description 14
239000002773 nucleotide Substances 0.000 claims description 13
125000003729 nucleotide group Chemical group 0.000 claims description 13
239000013612 plasmid Substances 0.000 claims description 13
108091010988 fibronectin binding proteins Proteins 0.000 claims description 10
244000005700 microbiome Species 0.000 claims description 10
SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 claims description 8
150000001413 amino acids Chemical group 0.000 claims description 8
108010063718 gamma-glutamylaspartic acid Proteins 0.000 claims description 8
102000053602 DNA Human genes 0.000 claims description 7
PWPBLZXWFXJFHE-RHYQMDGZSA-N Leu-Pro-Thr Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O PWPBLZXWFXJFHE-RHYQMDGZSA-N 0.000 claims description 6
XNQMZHLAYFWSGJ-HTUGSXCWSA-N Phe-Thr-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XNQMZHLAYFWSGJ-HTUGSXCWSA-N 0.000 claims description 6
LKUDRJSNRWVGMS-QSFUFRPTSA-N Val-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LKUDRJSNRWVGMS-QSFUFRPTSA-N 0.000 claims description 6
108010069205 aspartyl-phenylalanine Proteins 0.000 claims description 6
208000015181 infectious disease Diseases 0.000 claims description 6
VHRLUTIMTDOVCG-PEDHHIEDSA-N Val-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](C(C)C)N VHRLUTIMTDOVCG-PEDHHIEDSA-N 0.000 claims description 5
XXCDTYBVGMPIOA-FXQIFTODSA-N Glu-Asp-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XXCDTYBVGMPIOA-FXQIFTODSA-N 0.000 claims description 4
SBCYJMOOHUDWDA-NUMRIWBASA-N Glu-Asp-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SBCYJMOOHUDWDA-NUMRIWBASA-N 0.000 claims description 4
RNKSNIBMTUYWSH-YFKPBYRVSA-N L-prolylglycine Chemical compound [O-]C(=O)CNC(=O)[C@@H]1CCC[NH2+]1 RNKSNIBMTUYWSH-YFKPBYRVSA-N 0.000 claims description 4
AFWBWPCXSWUCLB-WDSKDSINSA-N Pro-Ser Chemical compound OC[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 AFWBWPCXSWUCLB-WDSKDSINSA-N 0.000 claims description 4
UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 claims description 4
XLDYBRXERHITNH-QSFUFRPTSA-N Val-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)C(C)C XLDYBRXERHITNH-QSFUFRPTSA-N 0.000 claims description 4
108010031719 prolyl-serine Proteins 0.000 claims description 4
108010029020 prolylglycine Proteins 0.000 claims description 4
JRCUFCXYZLPSDZ-ACZMJKKPSA-N Glu-Asp-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O JRCUFCXYZLPSDZ-ACZMJKKPSA-N 0.000 claims description 3
WOUIMBGNEUWXQG-VKHMYHEASA-N Ser-Gly Chemical compound OC[C@H](N)C(=O)NCC(O)=O WOUIMBGNEUWXQG-VKHMYHEASA-N 0.000 claims description 3
VBMOVTMNHWPZJR-SUSMZKCASA-N Thr-Thr-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VBMOVTMNHWPZJR-SUSMZKCASA-N 0.000 claims description 3
GBESYURLQOYWLU-LAEOZQHASA-N Val-Glu-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GBESYURLQOYWLU-LAEOZQHASA-N 0.000 claims description 3
DOURAOODTFJRIC-CIUDSAMLSA-N Asn-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N DOURAOODTFJRIC-CIUDSAMLSA-N 0.000 claims description 2
IESFZVCAVACGPH-PEFMBERDSA-N Glu-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O IESFZVCAVACGPH-PEFMBERDSA-N 0.000 claims description 2
QQLBPVKLJBAXBS-FXQIFTODSA-N Glu-Glu-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O QQLBPVKLJBAXBS-FXQIFTODSA-N 0.000 claims description 2
IQACOVZVOMVILH-FXQIFTODSA-N Glu-Glu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O IQACOVZVOMVILH-FXQIFTODSA-N 0.000 claims description 2
PHONAZGUEGIOEM-GLLZPBPUSA-N Glu-Glu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PHONAZGUEGIOEM-GLLZPBPUSA-N 0.000 claims description 2
STVHDEHTKFXBJQ-LAEOZQHASA-N Gly-Glu-Ile Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O STVHDEHTKFXBJQ-LAEOZQHASA-N 0.000 claims description 2
JSNNHGHYGYMVCK-XVKPBYJWSA-N Gly-Glu-Val Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O JSNNHGHYGYMVCK-XVKPBYJWSA-N 0.000 claims description 2
YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 claims description 2
GXDLGHLJTHMDII-WISUUJSJSA-N Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(O)=O GXDLGHLJTHMDII-WISUUJSJSA-N 0.000 claims description 2
UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 claims description 2
108010078274 isoleucylvaline Proteins 0.000 claims description 2
108010044311 leucyl-glycyl-glycine Proteins 0.000 claims description 2
238000004519 manufacturing process Methods 0.000 claims description 2
KXFCBAHYSLJCCY-ZLUOBGJFSA-N Asn-Asn-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O KXFCBAHYSLJCCY-ZLUOBGJFSA-N 0.000 claims 1
101100228200 Caenorhabditis elegans gly-5 gene Proteins 0.000 claims 1
FYYSIASRLDJUNP-WHFBIAKZSA-N Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FYYSIASRLDJUNP-WHFBIAKZSA-N 0.000 claims 1
LZEUDRYSAZAJIO-AUTRQRHGSA-N Glu-Val-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LZEUDRYSAZAJIO-AUTRQRHGSA-N 0.000 claims 1
JJGBXTYGTKWGAT-YUMQZZPRSA-N Gly-Pro-Glu Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O JJGBXTYGTKWGAT-YUMQZZPRSA-N 0.000 claims 1
XVZJRZQIHJMUBG-TUBUOCAGSA-N His-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC1=CN=CN1)N XVZJRZQIHJMUBG-TUBUOCAGSA-N 0.000 claims 1
CDGLBYSAZFIIJO-RCOVLWMOSA-N Ile-Gly-Gly Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O CDGLBYSAZFIIJO-RCOVLWMOSA-N 0.000 claims 1
WEDDFMCSUNNZJR-WDSKDSINSA-N Met-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O WEDDFMCSUNNZJR-WDSKDSINSA-N 0.000 claims 1
KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 claims 1
VPEVBAUSTBWQHN-NHCYSSNCSA-N Pro-Glu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O VPEVBAUSTBWQHN-NHCYSSNCSA-N 0.000 claims 1
108020004511 Recombinant DNA Proteins 0.000 claims 1
MUARUIBTKQJKFY-WHFBIAKZSA-N Ser-Gly-Asp Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MUARUIBTKQJKFY-WHFBIAKZSA-N 0.000 claims 1
VLMIUSLQONKLDV-HEIBUPTGSA-N Ser-Thr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VLMIUSLQONKLDV-HEIBUPTGSA-N 0.000 claims 1
JEDIEMIJYSRUBB-FOHZUACHSA-N Thr-Asp-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O JEDIEMIJYSRUBB-FOHZUACHSA-N 0.000 claims 1
BIYXEUAFGLTAEM-WUJLRWPWSA-N Thr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(O)=O BIYXEUAFGLTAEM-WUJLRWPWSA-N 0.000 claims 1
JLNMFGCJODTXDH-WEDXCCLWSA-N Thr-Lys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O JLNMFGCJODTXDH-WEDXCCLWSA-N 0.000 claims 1
BKVICMPZWRNWOC-RHYQMDGZSA-N Thr-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O BKVICMPZWRNWOC-RHYQMDGZSA-N 0.000 claims 1
239000003085 diluting agent Substances 0.000 claims 1
239000003937 drug carrier Substances 0.000 claims 1
101150089730 gly-10 gene Proteins 0.000 claims 1
108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 claims 1
239000008194 pharmaceutical composition Substances 0.000 claims 1
230000001737 promoting effect Effects 0.000 claims 1
108010048818 seryl-histidine Proteins 0.000 claims 1
108010061238 threonyl-glycine Proteins 0.000 claims 1
235000018102 proteins Nutrition 0.000 description 30
108020004414 DNA Proteins 0.000 description 17
206010052428 Wound Diseases 0.000 description 12
208000027418 Wounds and injury Diseases 0.000 description 12
238000000034 method Methods 0.000 description 12
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
239000012634 fragment Substances 0.000 description 11
239000006166 lysate Substances 0.000 description 10
102000004190 Enzymes Human genes 0.000 description 7
108090000790 Enzymes Proteins 0.000 description 7
229940088598 enzyme Drugs 0.000 description 7
239000000243 solution Substances 0.000 description 7
230000003053 immunization Effects 0.000 description 6
238000002649 immunization Methods 0.000 description 6
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 5
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
229960000723 ampicillin Drugs 0.000 description 5
210000004027 cell Anatomy 0.000 description 5
210000002808 connective tissue Anatomy 0.000 description 5
230000003252 repetitive effect Effects 0.000 description 5
239000013598 vector Substances 0.000 description 5
102000008186 Collagen Human genes 0.000 description 4
108010035532 Collagen Proteins 0.000 description 4
102000008946 Fibrinogen Human genes 0.000 description 4
108010049003 Fibrinogen Proteins 0.000 description 4
102000007547 Laminin Human genes 0.000 description 4
108010085895 Laminin Proteins 0.000 description 4
235000001014 amino acid Nutrition 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
229920001436 collagen Polymers 0.000 description 4
230000006378 damage Effects 0.000 description 4
229940012952 fibrinogen Drugs 0.000 description 4
239000012528 membrane Substances 0.000 description 4
102000005962 receptors Human genes 0.000 description 4
108020003175 receptors Proteins 0.000 description 4
238000012163 sequencing technique Methods 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
238000012360 testing method Methods 0.000 description 4
210000001519 tissue Anatomy 0.000 description 4
GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
238000003556 assay Methods 0.000 description 3
230000029087 digestion Effects 0.000 description 3
208000004396 mastitis Diseases 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000000758 substrate Substances 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
238000002255 vaccination Methods 0.000 description 3
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
102100034613 Annexin A2 Human genes 0.000 description 2
108090000668 Annexin A2 Proteins 0.000 description 2
241000020089 Atacta Species 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
241001200922 Gagata Species 0.000 description 2
FGGKGJHCVMYGCD-UKJIMTQDSA-N Glu-Val-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FGGKGJHCVMYGCD-UKJIMTQDSA-N 0.000 description 2
RFQATBGBLDAKGI-VHSXEESVSA-N Lys-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCCCN)N)C(=O)O RFQATBGBLDAKGI-VHSXEESVSA-N 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
239000004793 Polystyrene Substances 0.000 description 2
241000194017 Streptococcus Species 0.000 description 2
BNGDYRRHRGOPHX-IFFSRLJSSA-N Thr-Glu-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O BNGDYRRHRGOPHX-IFFSRLJSSA-N 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
244000052616 bacterial pathogen Species 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
239000000872 buffer Substances 0.000 description 2
239000013611 chromosomal DNA Substances 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
108010052305 exodeoxyribonuclease III Proteins 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
239000000203 mixture Substances 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
238000010397 one-hybrid screening Methods 0.000 description 2
244000052769 pathogen Species 0.000 description 2
229920000136 polysorbate Polymers 0.000 description 2
229920002223 polystyrene Polymers 0.000 description 2
239000000843 powder Substances 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
108010070643 prolylglutamic acid Proteins 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
230000007017 scission Effects 0.000 description 2
238000012216 screening Methods 0.000 description 2
230000000405 serological effect Effects 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
229940115920 streptococcus dysgalactiae Drugs 0.000 description 2
KPYXMALABCDPGN-HYOZMBHHSA-N (4s)-5-[[(2s)-6-amino-1-[[(2s,3s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2r)-1-[[2-[[2-[[(1s)-3-amino-1-carboxy-3-oxopropyl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]a Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN)CC1=CC=C(O)C=C1 KPYXMALABCDPGN-HYOZMBHHSA-N 0.000 description 1
101150098072 20 gene Proteins 0.000 description 1
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
244000153158 Ammi visnaga Species 0.000 description 1
235000010585 Ammi visnaga Nutrition 0.000 description 1
SVABRQFIHCSNCI-FOHZUACHSA-N Asp-Gly-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O SVABRQFIHCSNCI-FOHZUACHSA-N 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
206010005372 Blood blister Diseases 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
XQHSBNVACKQWAV-WHFBIAKZSA-N Gly-Asp-Asn Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XQHSBNVACKQWAV-WHFBIAKZSA-N 0.000 description 1
OMOZPGCHVWOXHN-BQBZGAKWSA-N Gly-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)CN OMOZPGCHVWOXHN-BQBZGAKWSA-N 0.000 description 1
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
102000002356 Nectin Human genes 0.000 description 1
108060005251 Nectin Proteins 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
241000282849 Ruminantia Species 0.000 description 1
206010039509 Scab Diseases 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
BPMRXBZYPGYPJN-WHFBIAKZSA-N Ser-Gly-Asn Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O BPMRXBZYPGYPJN-WHFBIAKZSA-N 0.000 description 1
JEHPKECJCALLRW-CUJWVEQBSA-N Ser-His-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JEHPKECJCALLRW-CUJWVEQBSA-N 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
206010061372 Streptococcal infection Diseases 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
GXUWHVZYDAHFSV-FLBSBUHZSA-N Thr-Ile-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GXUWHVZYDAHFSV-FLBSBUHZSA-N 0.000 description 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
230000004520 agglutination Effects 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
239000000427 antigen Substances 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
230000029586 bacterial cell surface binding Effects 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
239000011324 bead Substances 0.000 description 1
102000023732 binding proteins Human genes 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
230000037396 body weight Effects 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
239000007979 citrate buffer Substances 0.000 description 1
210000000078 claw Anatomy 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
230000006957 competitive inhibition Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
210000003038 endothelium Anatomy 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
238000003348 filter assay Methods 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
239000011521 glass Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
210000003709 heart valve Anatomy 0.000 description 1
238000011540 hip replacement Methods 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
230000028993 immune response Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
230000002934 lysing effect Effects 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
238000013507 mapping Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
125000000896 monocarboxylic acid group Chemical group 0.000 description 1
210000000214 mouth Anatomy 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
210000004417 patella Anatomy 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
239000012460 protein solution Substances 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
239000000523 sample Substances 0.000 description 1
238000012106 screening analysis Methods 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
235000020183 skimmed milk Nutrition 0.000 description 1
206010040882 skin lesion Diseases 0.000 description 1
231100000444 skin lesion Toxicity 0.000 description 1
239000002594 sorbent Substances 0.000 description 1
241000894007 species Species 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
238000001262 western blot Methods 0.000 description 1
238000009736 wetting Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Veterinary Medicine (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Communicable Diseases (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Chemical Or Physical Treatment Of Fibers (AREA)
Disintegrating Or Milling (AREA)

DK198902442A 1988-05-20 1989-05-19 Fibronectinbindende protein DK175809B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE8801894		1988-05-20
SE8801894A SE8801894D0 (sv)	1988-05-20	1988-05-20	Fibronektinbindande protein

Publications (3)

Publication Number	Publication Date
DK244289D0 DK244289D0 (da)	1989-05-19
DK244289A DK244289A (da)	1989-11-21
DK175809B1 true DK175809B1 (da)	2005-03-07

Family

ID=20372388

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK198902442A DK175809B1 (da)	1988-05-20	1989-05-19	Fibronectinbindende protein

Country Status (13)

Country	Link
US (3)	US5416021A (fi)
EP (1)	EP0343137B1 (fi)
JP (2)	JP2809428B2 (fi)
AT (1)	ATE226634T1 (fi)
AU (1)	AU628339B2 (fi)
CA (1)	CA1340910C (fi)
DE (1)	DE68929430T2 (fi)
DK (1)	DK175809B1 (fi)
ES (1)	ES2184728T3 (fi)
FI (1)	FI103049B (fi)
NO (1)	NO179412C (fi)
NZ (1)	NZ229206A (fi)
SE (1)	SE8801894D0 (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8801723D0 (sv) *	1988-05-06	1988-05-06	Staffan Normark	Fibronectin binding protein as well as its preparation
SE8801894D0 (sv) *	1988-05-20	1988-05-20	Alfa Laval Agri Int	Fibronektinbindande protein
SE8901687D0 (sv) *	1989-05-11	1989-05-11	Alfa Laval Agri Int	Fibronectin binding protein as well as its preparation
US5440014A (en) *	1990-08-10	1995-08-08	H+E,Uml/Oo/ K; Magnus	Fibronectin binding peptide
US5980908A (en) *	1991-12-05	1999-11-09	Alfa Laval Ab	Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
SE9202164D0 (sv) *	1992-07-14	1992-07-14	Stroemquist Miljoemedicinskkon	New polypeptide
GB9401689D0 (en) *	1994-01-28	1994-03-23	Univ Manchester	Diagnosis and treatment of endocarditis
US6660842B1 (en)	1994-04-28	2003-12-09	Tripep Ab	Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US6040137A (en) *	1995-04-27	2000-03-21	Tripep Ab	Antigen/antibody specification exchanger
US6933366B2 (en) *	1996-12-27	2005-08-23	Tripep Ab	Specificity exchangers that redirect antibodies to bacterial adhesion receptors
US20040247611A1 (en) *	1994-05-23	2004-12-09	Montana State University	Identification of pathogen-ligand interactions
US5648240A (en) *	1994-05-24	1997-07-15	Texas A&M University	MHC II analog from Staphylococcus aureus
US6355477B1 (en)	1996-09-16	2002-03-12	The Rockefeller University	Fibronectin and fibrinogen binding protein from group A streptococci
US5910441A (en) *	1996-09-16	1999-06-08	The Rockefeller University	DNA encoding fibronectin and fibrinogen binding protein from group A streptococci
US6685943B1 (en)	1997-01-21	2004-02-03	The Texas A&M University System	Fibronectin binding protein compositions and methods of use
GB9720633D0 (en) *	1997-09-29	1997-11-26	Univ Bristol	BHV-2 vector
US6703025B1 (en)	1998-08-31	2004-03-09	Inhibitex, Inc.	Multicomponent vaccines
US6692739B1 (en)	1998-08-31	2004-02-17	Inhibitex, Inc.	Staphylococcal immunotherapeutics via donor selection and donor stimulation
CA2446294A1 (en) *	2001-05-08	2002-11-14	Yi Xu	Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them
EP1395272A4 (en)	2001-05-11	2005-10-26	Texas A & M Univ Sys	METHOD AND COMPOSITIONS FOR INHIBITING THE THROMBIN-INDUCED BLOOD GRINDING
CA2450939C (en) *	2001-06-15	2012-11-06	Inhibitex, Inc.	Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
US7115264B2 (en) *	2001-11-05	2006-10-03	Inhibitex	Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections
EP1594898A2 (en)	2003-02-06	2005-11-16	Tripep AB	Glycosylated specificity exchangers
US7335359B2 (en)	2003-02-06	2008-02-26	Tripep Ab	Glycosylated specificity exchangers
MXPA05009351A (es) *	2003-03-07	2006-03-08	Wyeth Corp	Conjugados de polisacarido-proteina portadora adhesina superficial de estafilococo para inmunizacion contra infecciones nosocomiales.
DE102004038280B4 (de) *	2004-08-03	2006-07-27	W.C. Heraeus Gmbh	Verfahren zum Herstellen von Feinstlotpulvern
US20090092631A1 (en) *	2007-03-26	2009-04-09	Tripep Ab	Glycosylated specificity exchangers that induce an antibody dependent cellular cytotoxicity (adcc) response

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3917818A (en) *	1970-01-14	1975-11-04	Agricura Labor Ltd	Treatment of mastitis in cows, the product for this treatment and to the production of said product
DE2644622C3 (de) *	1976-10-02	1979-11-29	Behringwerke Ag, 3550 Marburg	Extraktion von Mikroorganismen und diese enthaltende diagnostische Mittel
SE445013B (sv) *	1979-06-21	1986-05-26	Landstingens Inkopscentral	Medel for att forebygga eller behandla infektioner hos menniskor och djur
US4425330A (en) *	1981-05-20	1984-01-10	Cornell Research Foundation, Inc.	Bovine mastitis vaccine and method for detecting efficacy thereof
SE446688C (sv) *	1982-09-14	1989-10-16	Magnus Hoeoek	Medel foer avlaegsnande av mikroorganismer fraan vaevnader, vilket bestaar av ett protein som kan bindas till mikroorganismerna
DK219084D0 (da) *	1984-05-02	1984-05-02	Frederik Carl Peter Lindberg	Antigen
SE454403B (sv) *	1984-05-30	1988-05-02	Alfa Laval Agri Int	Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel
US5189015A (en) *	1984-05-30	1993-02-23	Alfa-Laval Agri International Ab	Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability
US5571514A (en) *	1987-06-01	1996-11-05	Alfa Laval Ab	Fibronectin binding protein as well as its preparation
US5320951A (en) *	1987-06-01	1994-06-14	Hoeoek Magnus	Fibronectin binding protein as well as its preparation
SE8702272L (sv) *	1987-06-01	1988-12-02	Alfa Laval Agri Int	Fibronektinbindande protein samt dess framstaellning
SE8801723D0 (sv) *	1988-05-06	1988-05-06	Staffan Normark	Fibronectin binding protein as well as its preparation
SE8801894D0 (sv) *	1988-05-20	1988-05-20	Alfa Laval Agri Int	Fibronektinbindande protein
US5789549A (en) *	1988-05-20	1998-08-04	Alfa Laval Agri International Aktiebolag	Fibronectin binding protein
SE8901687D0 (sv) *	1989-05-11	1989-05-11	Alfa Laval Agri Int	Fibronectin binding protein as well as its preparation
SE9002617D0 (sv) *	1990-08-10	1990-08-10	Alfa Laval Agri Int	A fibronectin binding peptide
US5440014A (en) *	1990-08-10	1995-08-08	H+E,Uml/Oo/ K; Magnus	Fibronectin binding peptide
US5725804A (en) *	1991-01-15	1998-03-10	Hemosphere, Inc.	Non-crosslinked protein particles for therapeutic and diagnostic use
US5648240A (en) *	1994-05-24	1997-07-15	Texas A&M University	MHC II analog from Staphylococcus aureus
US5910441A (en) *	1996-09-16	1999-06-08	The Rockefeller University	DNA encoding fibronectin and fibrinogen binding protein from group A streptococci

1988
- 1988-05-20 SE SE8801894A patent/SE8801894D0/xx unknown
1989
- 1989-05-16 EP EP89850161A patent/EP0343137B1/en not_active Expired - Lifetime
- 1989-05-16 ES ES89850161T patent/ES2184728T3/es not_active Expired - Lifetime
- 1989-05-16 AT AT89850161T patent/ATE226634T1/de not_active IP Right Cessation
- 1989-05-16 DE DE68929430T patent/DE68929430T2/de not_active Expired - Lifetime
- 1989-05-18 FI FI892408A patent/FI103049B/fi not_active IP Right Cessation
- 1989-05-19 NO NO892033A patent/NO179412C/no not_active IP Right Cessation
- 1989-05-19 DK DK198902442A patent/DK175809B1/da not_active IP Right Cessation
- 1989-05-19 AU AU34981/89A patent/AU628339B2/en not_active Expired
- 1989-05-19 NZ NZ229206A patent/NZ229206A/en unknown
- 1989-05-19 CA CA000600187A patent/CA1340910C/en not_active Expired - Lifetime
- 1989-05-20 JP JP1125593A patent/JP2809428B2/ja not_active Expired - Lifetime
1993
- 1993-09-23 US US08/125,222 patent/US5416021A/en not_active Expired - Lifetime
1995
- 1995-04-25 US US08/428,713 patent/US5866541A/en not_active Expired - Lifetime
1997
- 1997-08-01 US US08/904,179 patent/US6086895A/en not_active Expired - Lifetime
1998
- 1998-02-19 JP JP05430398A patent/JP3190307B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NO892033L (no)	1989-11-21
CA1340910C (en)	2000-02-22
SE8801894D0 (sv)	1988-05-20
DK244289D0 (da)	1989-05-19
FI103049B1 (fi)	1999-04-15
DE68929430T2 (de)	2003-07-03
AU3498189A (en)	1989-11-23
JPH10286095A (ja)	1998-10-27
ES2184728T3 (es)	2003-04-16
AU628339B2 (en)	1992-09-17
NO179412B (no)	1996-06-24
NO179412C (no)	1996-10-02
ATE226634T1 (de)	2002-11-15
DK244289A (da)	1989-11-21
JP2809428B2 (ja)	1998-10-08
US5416021A (en)	1995-05-16
NO892033D0 (no)	1989-05-19
DE68929430D1 (de)	2002-11-28
US6086895A (en)	2000-07-11
US5866541A (en)	1999-02-02
FI892408A0 (fi)	1989-05-18
JP3190307B2 (ja)	2001-07-23
FI892408L (fi)	1989-11-21
NZ229206A (en)	1992-06-25
EP0343137A1 (en)	1989-11-23
FI103049B (fi)	1999-04-15
EP0343137B1 (en)	2002-10-23
JPH0284182A (ja)	1990-03-26

Publication	Publication Date	Title
DK175809B1 (da)	2005-03-07	Fibronectinbindende protein
US5175096A (en)	1992-12-29	Dna encoding a fibronectin binding protein as well as its preparation
Probert et al.	1998	Identification of a 47 kDa fibronectin‐binding protein expressed by Borrelia burgdorferi isolate B31
KR100871330B1 (ko)	2008-12-01	응고효소 음성 포도상구균 유래의 폴리펩타이드 및폴리뉴클레오타이드
US6264954B1 (en)	2001-07-24	Haemophilus outer membrane protein
US5789549A (en)	1998-08-04	Fibronectin binding protein
EP0348725A2 (en)	1990-01-03	Species-specific epitode of chlamydia trachomatis and antibodies that recognize the same
US5281694A (en)	1994-01-25	Methods and compositions for production of mycoplasmal adhesins
JPH05502046A (ja)	1993-04-15	フィブロネクチン結合タンパク質
US6586580B1 (en)	2003-07-01	Protein rib, a cell surface protein that confers immunity to many strains of the group B Streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
AU702144B2 (en)	1999-02-11	Diagnosis and treatment of infections due to streptococci and enterococci
JPH03115299A (ja)	1991-05-16	フイブロネクチン結合タンパク質及びその製法
JPH10201484A (ja)	1998-08-04	新規ＦｔｓＬ
US5919640A (en)	1999-07-06	Streptococcus suis adhesin protein and method for producing it
IE83742B1 (en)		Fibronectin binding protein
AU3094700A (en)	2000-07-12	Novel fibronectin-binding protein
JP2000509984A (ja)	2000-08-08	新規化合物
JPH11137271A (ja)	1999-05-25	新規ｐｃｒＡ
JPH10290693A (ja)	1998-11-04	新規フィブロネクチン結合蛋白化合物

Legal Events

Date	Code	Title	Description
2009-06-08	PUP	Patent expired